Suppression of conditioned fear by administration of CRF receptor antagonist CP-154,526

Pharmacopsychiatry

Volumn 33, Issue 5, 2000, Pages 189-193

  Hikichi, T ^a   Akiyoshi, J ^a   Yamamoto, Y ^a   Tsutsumi, T ^a   Isogawa, K ^a   Nagayama, H ^a  

^a OITA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BUTYL[2,5 DIMETHYL 7 (2,4,6 TRIMETHYLPHENYL) 7H PYRROLO[2,3 D]PYRIMIDIN 4 YL]ETHYLAMINE; CORTICOTROPIN RELEASING FACTOR ANTAGONIST; CORTICOTROPIN RELEASING FACTOR RECEPTOR;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ANXIETY NEUROSIS; ARTICLE; CONDITIONING; DOSE TIME EFFECT RELATION; DRUG RECEPTOR BINDING; FEAR; MALE; MOTOR ACTIVITY; NONHUMAN; PRIORITY JOURNAL; RAT; SHOCK;

EID: 0033808075     PISSN: 01763679     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2000-7587     Document Type: Article

References (31)

1. CRF antagonist reverses the 'anxiogenic' response to ethanol withdrawal in the rat
2. Double dissociation of conditioning and declarative knowledge relative to the amygdala and hippocampus in humans
3. Corticotropin releasing factor (CRF) receptor antagonist blocks activation and 'anxiogenic' actions of CRF in the rat
4. Alterations in corticotropin-releasing factor-like immunoreactivity in discrete rat brain regions after acute and chronic stress
5. Physiological and behavioral responses to corticotropin-releasing factor administration: Is CRFa mediator of anxiety or stress responses?
6. Conditional and unconditional components of post-shock freezing
7. Types of stressful life event and the onset of anxiety and depressive disorders
8. The rationale for corticotropin-releasing hormone receptor (CRH-R) antagonists to treat depression and anxiety
9. Serotonergic activation reduces defensive freezing in the conditioned fear paradigm
10. Alpha-helical CRF(9,41) prevents anxiogenic-like effect of NPY Y1 receptor antagonist BIBP3226 in rats
11. The role of corticotropin-releasing factor in behavioural responses to stress
12. Impaired fear conditioning following unilateral temporal lobectomy in humans
13. Corticotropin-releasing factor: Long-lasting facilitation of the acoustic startle reflex
14. A non peptidic corticotropin releasing factor receptor antagonist attenuates fever and exhibits anxiolytic-like activity
15. Central corticotropin-releasing factor and benzodiazepine receptor systems are involved in the social isolation stress-induced decrease in ethanol sleep in mice
16. Physiology and pharmacology of corticotropin releasing factor
17. The effects of alprazolam on corticotropin-releasing factor neurons in the rat brain: Acute time course, chronic treatment and abrupt withdrawal
18. The role of corticotropin-releasing factor in the pathophysiology of affective and anxiety disorders: Laboratory and clinical studies
19. The effect of alprazolam on corticotropin-releasing factor neurons in the anxiety disorders
20. Reduced TSH and prolactin responses to TRH in patients with panic disorder
21. Activation of noradrenergic neurons in the locus coeruleus by corticotropin-releasing factor. A microdialysis study
22. CP-154,526: A potent and selective nonpeptide antagonist of corticotropin releasing factor receptors
23. Alterations in local cerebral glucose utilization following central administration of corticotropin-releasing factor in rats
24. The corticotropin-releasing hormone test in patients with posttraumatic stress disorder
25. Corticotropin releasing factor receptor 1-deficient mice display decreased anxiety, impaired stress response, and aberrant neuroendocrine development
26. Corticotropin-releasing factor produces behavioral activation in rats
27. Attenuation of stress-induced behavior by antagonism of corticotropin-releasing factor receptors in the central amygdala in the rat
28. Impaired stress response and reduced anxiety in mice lacking a functional corticotropin-releasing hormone receptor 1110ee comments
29. Disruption of the glucocorticoid receptor gene in the nervous system results in reduced anxiety
30. Activation of noradrenergic locus coeruleus neurons by hemodynamic stress is due to local release of corticotropin-releasing factor
31. In vivo and in vitro characterization of Antalarmin, a nonpeptde corticotropin-releasing hormone (CRH) receptor antagonists: Suppression of pituitary ACTH release and peripheral inflammation